Virginia Tech®home
Wenyan Ji

Wenyan Ji earned her MA degree in Biostatistics from the SUNY University at Buffalo (UB) (2018). She then worked for Roswell Comprehensive Cancer Center for three years as a biostatistician. She worked with Department of Urology and Surgical Oncology in pre-clinical, clinical and translational studies for a variety of disease settings and outcomes, including but not limited to cardiovascular disease, breast cancer, prostate cancer, gastric cancer, leukemia, Covid-19 related disease, opioid use, healthy lifestyle and tobacco use, where she participated in study design, study analysis and manuscript writing. She is now working for Center for Biostatistics & Health Data Science (CBHDS) as a research associate. She has authored/co-authored over 30 peer-reviewed scientific publications.

Jason Ricciuti, Aaron Varghese, Steven Gallo, Deanna Argentieri, Wenyan Ji, Alan Hutson, Jaron Mark, Emese Zsiros (2021). Using restrictive opioid protocols for postsurgical pain management does not compromise patient reported outcomes. Gynecologic Oncology, 162, S325-S326.

Emam, A., Hermann, G., Attwood, K., Ji, W., James, G., Kuettel, M., & Mohler, J. (2021). Oncologic outcome of radical  prostatectomy  versus  radiotherapy  as  primary  treatment  for  high  and  very  high  risk  localized prostate cancer. The Prostate, 81(4), 223–230.

Gupta, M., Gosain, R., Sarma, M., Perimbeti, S., Attwood, K., Ji,  W., Gandhi, S., & Abdou, Y. (2021). Abstract   PS7-29: Racial disparities in breast cancer outcomes: A SEER population based study. Cancer Research, 81(4 Supplement), PS7-29-PS7-29.

Przespolewski, A., Muppidi, M., Freyer, C., Ji, W., Cronin, T., Thota, S., Griffiths, E., Thompson, J., Ontiveros, E., Baron, J., & others (2021). Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with  adverse  karyotype  and  prior  hypomethylating  therapy. Leukemia & Lymphoma, 1–6.

Gabriel, E., Kim, M., Fisher, D., Mangum, C., Attwood, K., Ji, W., Mukhopadhyay, D., Bagaria, S., Robertson, M., Dinh, T., & others (2021). A pilot trial of intravital microscopy  in  the  study  of  the  tumor  vasculature  of  patients with peritoneal carcinomatosis. Scientific reports, 11(1), 1–13.

Mangum, C., Kim, M., Fisher, D., Attwood, K., Ji, W., Mukhopadhyay, D., Bagaria, S., Robertson, M., Dinh, T., Knutson, K., & others (2021). Intravital Mroscopy in  the  Study  of  the  Tumor  Vasculature  of  Patients  with  Peritoneal Carcinomatosis. ANNALS OF SURGICAL ONCOLOGY, 28(SUPPL 1), S115-S115.

Farrugia, M., Erickson, K., Wendel, E., Platek, M., Ji, W., Attwood, K., Ma, S., Gu, F., Singh, A., & Ray, A. (2021). Change in Physical Performance Correlates with Decline in Quality of Life and Frailty Status in Head and Neck Cancer Patients Undergoing Radiation with and without Chemotherapy. Cancers, 13(7), 1638.

Ricciuti, J., Gallo, S., Argentieri, D., Visco, P., Attwood, K., Ji, W., Fabiano, A., Hennon, M., Kauffman, E., Wooten, K., & others (2021). Less is more: Postoperative pain management using restrictive  opioid  protocols  in  all surgical services in a comprehensive cancer center. Journal of Clinical Oncology, 39(15_suppl), 103-103.

Gandhi, S., Pandey, M., Attwood, K., Ji, W., Witkiewicz, A., Knudsen, E., Allen, C., Tario, J., Wallace, P., Cedeno, C., & others (2021). Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clinical  Cancer Research, 27(1), 87–95.

Trumbull, D., Lemini, R., Vico, T., Jorgensen, M., Attwood, K., Ji, W., Brady, M., Gabriel, E., & Kukar, M. (2021). Prognostic significance of complete  pathologic  response  obtained  with  chemotherapy  versus  chemoradiotherapy in gastric cancer. Annals of Surgical Oncology, 28(2), 766–773.

Peng, J., Brady, M., Ji, W., Attwood, K., Kukar, M., & Hochwald, S. (2020). Is the National Surgical Quality Improvement  Program  Calculator  Predictive  of  Outcomes  After  Minimally  Invasive  Esophagectomy?.  ANNALS  OF SURGICAL ONCOLOGY, 27(SUPPL 1), S166-S166.

Peng, J., Brady, M., Ji, W., Attwood, K., Hochwald, S., & Kukar, M. (2020). Predictors of Early Recurrence After Resection for Esophageal and Gastroesophageal Junction Cancer. ANNALS OF SURGICAL ONCOLOGY, 27(SUPPL    1), S185-S185.

Peng, J., Brady, M., Ji, W., Attwood, K., Hochwald, S., & Kukar, M. (2020). Impact of Smoking  Status  on Postoperative  and  Oncologic  Outcomes  After  Esophagectomy  for  Gastroesophageal  Junction  Cancer.   ANNALS   OF SURGICAL ONCOLOGY, 27(SUPPL 1), S166-S167.

Hanif, A., Khan, S., Mantri, N., Hanif, S., Saleh, M., Alla, Y., Chinta, S., Shrestha, N., Ji, W., Attwood, K., & others (2020). Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Annals of hematology, 99(10), 2323–2328.

Gupta, M., Gosain, R., Sarma, M., Perimbeti, S., Kristopher, A., Ji, W., Gandhi, S., & Abdou, Y. (2020). Abstract PO-221: Racial disparities in breast cancer  characteristics  and  outcomes  among  Hispanic  and  White  patients.  Cancer Epidemiology and Prevention Biomarkers, 29(12 Supplement), PO-221-PO-221.

Abdou, Y., Elkhanany, A., Attwood, K., Ji, W., Takabe, K., & Opyrchal, M. (2019). Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast  cancer  research  and  treatment,  178(3),  523– 533.

Przespolewski, A., Freyer, C., Ji, W., Cronin, T., Thota, S., Griffiths, E., Thompson,  J.,  Elshoury,  A.,  Baron,  J., Walsh, M., & others. (2019).  Cladribine,  Cytarabine,  Granulocyte  Colony  Stimulating  Factor  ±  Mitoxantrone  (CLAG ± M) Is Highly  Effective  Therapy  for  Secondary  and  Relapsed/Refractory  Acute  Myeloid  Leukemia.  Blood, The Journal of the American Society of Hematology, 134(Supplement_1), 1361-1361.

Lone*, Z., Khan, H., Steele, M., Bizovi, J., Elsayed, A., Aldhaam, N., Hussein, A., Ji, W., Attwood, K., Davidson, R., & others (2019). PD63-11 ART HEALS: DOES ART THERAPY HELP IN THE RECOVERY OF PATIENTS AFTER MAJOR ONCOLOGIC SURGERY?. The Journal of Urology, 201(Supplement 4), e1116–e1116.

Lemini, R., Attwood, K., Almerey, T., Gunn, J., Yeager, T., Elias, A., Partain, K., Jorgensen, M., Ji, W., Gabriel, E., & others (2019). Is metastasectomy a worthy  option?—the  role  of  surgery  in  metastatic  colon  cancer  to  liver  and lungs. Journal of gastrointestinal oncology, 10(6), 1032.

Yeager, T., Partain, K., Gunn, J., Almerey, T., Lemini, R., Ji, W., Attwood, K., Bagaria, S., & Gabriel, E. (2019). The Prognostic Significance of the Lymph Node Ratio in Gastric Neuroendocrine Tumors. ANNALS OF SURGICAL ONCOLOGY, 26, S130–S130.

Terhune, J., Fisher, D., Khushalani, N., Ji, W., Attwood, K., & Skitzki, J. (2019). Identification of Immunotherapy Targets After IL-2 Treatment. ANNALS OF SURGICAL ONCOLOGY, 26, S162–S163.

Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017). Leveraging physiology for precision drug delivery. Physiological reviews, 97(1), 189–225.

Sun, W., Ji, W., Hu, Q., Yu, J., Wang, C., Qian, C., Hochu, G., & Gu, Z. (2016). Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine. Biomaterials, 96, 1–10.

Ji, W., Sun, W., Feng, J., Song, T., Zhang, D., Ouyang, P., Gu, Z., & Xie, J. (2015). Characterization of a novel N-acetylneuraminic  acid  lyase   favoring   industrial   N-acetylneuraminic   acid   synthesis   process.   Scientific   reports, 5(1), 1–9.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Titelbild: Self-Assembled DNA Nanoclews for the  Efficient   Delivery   of   CRISPR–Cas9   for   Genome   Editing   (Angew.   Chem.   41/2015).   Angewandte  Chemie, 127(41), 12045–12045.

Sun, W., Ji,  W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Self-assembled DNA nanoclews for the  efficient delivery of CRISPR–Cas9 for genome editing. Angewandte Chemie, 127(41), 12197–12201.

Sun, W., Ji,  W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). CRISPR–Cas9 Delivery by DNA Nanoclews  for Efficient Genome Editing. MRS/ASM/AVS 2015, 51.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Efficient delivery of CRISPR-Cas9 for genome editing via self-assembled DNA nanoclews. Angewandte Chemie (International ed. in English), 54(41), 12029.

Sun, W., Ji, W., Hall, J., Hu, Q., Wang, C., Beisel, C., & Gu, Z. (2015). Cover Picture: Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing (Angew. Chem. Int. Ed. 41/2015). Angewandte Chemie International Edition, 54(41), 11877–11877.

Sun, W., Ji, W., Li, N., Tong, P., Cheng, J., He, Y., Chen, Y., Chen, X., Wu, J., Ouyang, P., & others (2013). Construction and expression of a polycistronic plasmid encoding N-acetylglucosamine 2-epimerase and N-acetylneuraminic acid lyase simultaneously for production of N-acetylneuraminic  acid.  Bioresource  technology, 130, 23–29.